Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)

Juraj Koska (Creator)
Daniel S. Nuyujukian (Creator)
Gideon Bahn (Creator)
Jin J. Zhou (University of California at Los Angeles) (Creator)
Peter D. Reaven (University of Arizona, Phoenix VA Healthcare System, Department of Veterans Affairs) (Creator)

Epidemiology and Biostatistics

Dataset

Description

Abstract Aims Low C-peptide levels, indicating beta-cell dysfunction, are associated with increased within-day glucose variation and hypoglycemia. In advanced type 2 diabetes, severe hypoglycemia and increased glucose variation predict cardiovascular (C...

Date made available	2021
Publisher	figshare

DOI
10.6084/m9.figshare.c.5743477.v1

Access Dataset

Creative Commons Attribution 4.0 International

1 Article

Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)
Koska, J., Nuyujukian, D. S., Bahn, G. D., Zhou, J. J. & Reaven, P. D., Dec 2021, In: Cardiovascular Diabetology. 20, 1, 232.
Research output: Contribution to journal › Article › peer-review

Open Access
10 Scopus citations

Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)

Description

DOI

Access Dataset

Research output

Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)

Cite this